B-RAF mutations are found in ∼8% of all cancers and at high frequencies in malignant melanoma, colon and thyroid cancers 1. The clinical promise of selective RAF inhibitors has widespread ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results